Clinical Trial Update: A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update outlines an evaluation of CJH1 (CLR4001) for Parkinson's disease across Phase 1 and Phase 2, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CJH1 (CLR4001) (CLR4001)

Snippet

Sponsor: Alexandra Marine and General Hospital | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: UNKNOWN